Selected PUBLICATIONS
Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022) Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology. https://doi.org/10.1007/s00213-022-06083-y.
Abbas A, Carter A, Jeanne T, Knox R, Korthuis TP, Hamade A, Stauffer CS, Uehling J. (2021) Oregon Psilocybin Advisory Board Rapid Evidence Review and Recommendations. Oregon Health Authority.
Stauffer CS, Morrison TE, Meinzer NK, Leung D, Buffington J, Sheh EG, Neylan TC, et al. (2022) Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial. Psychiatry Research. 308:114340. https://doi.org/10.1016/j.psychres.2021.114340.
Stauffer CS, Samson S, Hickok A, Hoffman WF, Batki SL. (2021) Intranasal oxytocin for stimulant use disorder among male Veterans enrolled in an opioid treatment program: A randomized controlled trial. Frontiers in Psychiatry. 12:804997. doi: 10.3389/fpsyt.2021.804997.
Thorson KR, McKernan SM, West TV, Woolley JD, Mendes WB, Stauffer CS. (2021). Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial. Scientific Reports. 11:21004. https://doi.org/10.1038/s41598-021-99957-8.
Stauffer CS, Anderson BT, Ortigo KM, Woolley J. (2020). Psilocybin-assisted group therapy and attachment: Observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience. ACS Pharmacology & Translational Science. http://dx.doi.org/10.1021/acsptsci.0c00169.
Anderson BT, Danforth A, Daroff R, Stauffer CS, Ekman E, Agin-Liebes G, Trope A, et al. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine. 100538.
Stauffer CS, Moschetto JM, McKernan S, Meinzer NK, Chiang C, Rapier R, Hsiang E, et al. (2020). Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial. Journal of Substance Abuse Treatment. 108059.
Stauffer CS, Meinzer NK, Morrison T, Wen J-H, Radanovich L, Leung D, Niles A, et al. (2019). Effects of oxytocin administration on cue-induced craving in co-occurring alcohol use disorder and PTSD: a within-participant randomized clinical trial. Alcoholism: Clinical and Experimental Research. 43(12):2627-2636. PMID: 31610033.
Rapier R, McKernan SM, Stauffer CS. (2019). The inverse relationship between perceived social support and substance use frequency in socially stigmatized populations. Addictive Behaviors. 10:100188. PMID: 31294075
Trope A, Anderson BT, Hooker AR, Glick G, Stauffer CS, Woolley JD. (2019). Psychedelic-assisted group therapy: A systematic review. Journal of Psychoactive Drugs. 51(2):174-188. PMID: 30950777.
Stauffer CS, Dobberteen L, Woolley JD. (2017). American Alcohol Photo Stimuli (AAPS): A standardized set of alcohol and matched non-alcohol images. The American Journal of Drug and Alcohol Abuse. 43(6):647-655. PMID: 27893279.
Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD. (2016). A two-week pilot study of intranasal oxytocin for cocaine dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction Research and Theory. 24(6):480-498. PMID: 28503120.
Stauffer CS & Woolley JD. (2014). Can we bottle psychosocial treatments for addiction? The role of oxytocin. J Clin Psychiatry. 75(9):1028-9. PMID: 25295428.
A complete list of of publications and other research is available at the links below:
Stauffer CS, Brown MR, Adams D, Cassity M, Sevelius J. (2022) MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.932605.